Terrence Allen Rogalla, MSSW, LCSW, CEAP | |
738 Arrowhead Blvd, Wilton, WI 54670-6006 | |
(608) 343-8681 | |
Not Available |
Full Name | Terrence Allen Rogalla |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 738 Arrowhead Blvd, Wilton, Wisconsin |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659403947 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | 6802-123 (Wisconsin) | Primary |
Mailing Address | Practice Location Address |
---|---|
Terrence Allen Rogalla, MSSW, LCSW, CEAP 738 Arrowhead Blvd, Wilton, WI 54670-6006 Ph: (608) 343-8681 | Terrence Allen Rogalla, MSSW, LCSW, CEAP 738 Arrowhead Blvd, Wilton, WI 54670-6006 Ph: (608) 343-8681 |
News Archive
Recent recommendations by the Institute of Medicine (IOM) call for women who are overweight or obese to gain more weight than they should, a Saint Louis University obstetrician wrote in a January commentary for Obstetrics & Gynecology.
When selecting a health insurance plan, both uninsured, tech-savvy young adults and uninsured low-income, rural adults had trouble understanding their insurance options. Many selected insurance plans that were more expensive than required for their health care needs, finds a new study in Health Services Research.
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd. today announced that Acetadote® (acetylcysteine) Injection has been granted regulatory approval for marketing and sale in Australia. Acetadote, an injectable drug used to treat acetaminophen (paracetamol) overdose, was approved by the Therapeutic Goods Administration (TGA), the government agency responsible for regulating drugs and medical devices in Australia.
In an attempt to make breathing devices available to low-income areas, scientists have developed the LeVe CPAP System for respiratory support to treat COVID.
A non-invasive fingertip test can identify coronary disease at its earliest stages and may provide an easy to use tool for daily clinical practice, according to a recent study published in the Journal of the American College of Cardiology.
› Verified 4 days ago